Unknown PHASE2 INTERVENTIONAL 1-arm NCT02855788

Metronomic Chemotherapy in Advanced Gastric Cancer

Phase II Study of Metronomic Chemotherapy Using POLF Regimen in the Treatment of Advanced Gastric Cancer

Sponsor: Huashan Hospital

Conditions Locally Advanced Gastric Cancer Metastatic Gastric Cancer

Interventions Paclitaxel 60mg/m2, Oxaliplatin 50mg/m2, Leucovorin 20mg/m2, and 5-FU 425mg/m2 IV weekly

Updated 5 times since 2017 Last updated: Aug 2, 2016 Started: May 31, 2015 Primary completion: Jul 31, 2018 Completion: Oct 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Locally Advanced Gastric Cancer and Metastatic Gastric Cancer, this trial is ongoing. The trial is conducted by Huashan Hospital and has accumulated 5 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Nov 2018 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jan 2017 — Nov 2018 [monthly]

Recruiting PHASE2

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Huashan Hospital
Seattle Integrative Cancer Center

Data source: Huashan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seattle, United States
• Shanghai, China